The DOI matches its Crossref record; 40 of the 40 references it cites were found in a registry or an index.
Impact of T-cell costimulation modulation in patients with undifferentiated inflammatory arthritis or very early rheumatoid arthritis: a clinical and imaging study of abatacept (the ADJUST trial)
Open accessAbstract
Background Several agents provide treatment for established rheumatoid arthritis (RA), but a crucial therapeutic goal is to delay/prevent progression of undifferentiated arthritis (UA) or very early RA. Objective To determine the impact of T-cell costimulation modulation in patients with UA or very early RA. Methods In this double-blind, phase II, placebocontrolled, 2-year study, anti-cyclic citrullinated peptide (CCP)2-positive patients with UA (not fulfilling the ACR criteria for RA) and clinical synovitis of two or more joints were randomised to abatacept (∼10 mg/kg) or placebo for 6 months; the study drug was then terminated. The primary end point was development of RA (by ACR criteria) at year 1. Patients were monitored by radiography, MRI, CCP2, rheumatoid factor and 28 joint count Disease Activity Score (DAS28) over 2 years. Results At year 1, 12/26 (46%) abatacept-treated versus 16/24 (67%) placebo-treated patients developed RA (difference (95% CI) −20.5% (−47.4% to 7.8%)). Adjusted mean changes from baseline to year 1 in Genant-modified Sharp radiographic scores for abatacepttreated versus placebo-treated patients, respectively, were 0 versus 1.1 for total score, and 0 versus 0.9 for erosion score. Mean changes from baseline to year 1 in MRI erosion, osteitis and synovitis scores were 0, 0.2 and 0.2, respectively, versus 5.0, 6.7 and 2.3 in the abatacept versus placebo groups. Safety was comparable between groups; serious adverse events occurred in one patient (3.6%) in each group. Conclusion Abatacept delayed progression of UA/very early RA in some patients. An impact on radiographic and MRI inhibition was seen, which was maintained for 6 months after treatment stopped. This suggests that it is possible to alter the progression of RA by modulating T-cell responses at a very early stage of disease. Trial registration number NCT00124449.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Arnett, F. C., Edworthy, S. M., Bloch, D. A., Mcshane, D. J., Fries, J. F., Cooper, N. S., Healey, L. A., Kaplan, S. R., Liang, M. H., Luthra, H. S., et al. (1988) · Arthritis & Rheumatism · doi:10.1002/art.1780310302 · Cited by 19,752
Goekoop‐Ruiterman, Y. P. M., De Vries‐Bouwstra, J. K., Allaart, C. F., Van Zeben, D., Kerstens, P. J. S. M., Hazes, J. M. W., Zwinderman, A. H., Ronday, H. K., Han, K. H., Westedt, M. L., et al. (2005) · Arthritis & Rheumatism · doi:10.1002/art.21405 · Cited by 1,460
Grigor, C., Capell, H., Stirling, A., McMahon, A. D., Lock, P., Vallance, R., Porter, D., & Kincaid, W. (2004) · The Lancet · doi:10.1016/s0140-6736(04)16676-2 · Cited by 1,435
Rudwaleit, M., Landewé, R., van der Heijde, D., Listing, J., Brandt, J., Braun, J., Burgos-Vargas, R., Collantes-Estevez, E., Davis, J., Dijkmans, B., et al. (2009) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2009.108217 · Cited by 941
Self-citationWells, G., Becker, J.-C., Teng, J., Dougados, M., Schiff, M., Smolen, J., Aletaha, D., & van Riel, P. L. C. M. (2009) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2007.084459 · Cited by 878
Self-citationEmery, P., Breedveld, F. C., Hall, S., Durez, P., Chang, D. J., Robertson, D., Singh, A., Pedersen, R. D., Koenig, A. S., & Freundlich, B. (2008) · The Lancet · doi:10.1016/s0140-6736(08)61000-4 · Cited by 821
Self-citationØstergaard, M., PETERFY, C. G., Conaghan, P. G., McQueen, F. M., Bird, P., Ejbjerg, B., Shnier, R., O’Connor, P., Klarlund, M., Emery, P., et al. (2003) · PubMed · Cited by 700
Self-citationRHEUMATOID ARTHRITIS: A DISEASE OF T-LYMPHOCYTE/MACROPHAGE IMMUNOREGULATION
Janossy, G., Duke, O., Poulter, L. W., Panayi, G., Bofill, M., & Goldstein, G. (1981) · The Lancet · doi:10.1016/s0140-6736(81)91107-7 · Cited by 655
Huizinga, T. W. J., Amos, C. I., van der Helm‐van Mil, A. H. M., Chen, W., van Gaalen, F. A., Jawaheer, D., Schreuder, G. M. T., Wener, M., Breedveld, F. C., Ahmad, N., et al. (2005) · Arthritis & Rheumatism · doi:10.1002/art.21385 · Cited by 593
Raza, K., Falciani, F., Curnow, S. J., Ross, E. J., Lee, C.-Y., Akbar, A. N., Lord, J. M., Gordon, C., Buckley, C. D., & Salmon, M. (2005) · Arthritis Research & Therapy · doi:10.1186/ar1733 · Cited by 515
van Dongen, H., van Aken, J., Lard, L. R., Visser, K., Ronday, H. K., Hulsmans, H. M. J., Speyer, I., Westedt, M., Peeters, A. J., Allaart, C. F., et al. (2007) · Arthritis & Rheumatism · doi:10.1002/art.22525 · Cited by 413
Smolen, J. S., Landewé, R., Breedveld, F. C., Dougados, M., Emery, P., Gaujoux-Viala, C., Gorter, S., Knevel, R., Nam, J., Schoels, M., et al. (2010) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2009.126532 · Cited by 409
Self-citationNam, J. L., Winthrop, K. L., van Vollenhoven, R. F., Pavelka, K., Valesini, G., Hensor, E. M. A., Worthy, G., Landewé, R., Smolen, J. S., Emery, P., et al. (2010) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2009.126573 · Cited by 406
Self-citationPredominantly T-Cell Infiltrate in Rheumatoid Synovial Membranes
van Boxel, J. A., & Paget, S. A. (1975) · New England Journal of Medicine · doi:10.1056/nejm197509112931101 · Cited by 386
Hetland, M. L., Ejbjerg, B., Hørslev-Petersen, K., Jacobsen, S., Vestergaard, A., Jurik, A. G., Stengaard-Pedersen, K., Junker, P., Lottenburger, T., Hansen, I., et al. (2009) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2008.088245 · Cited by 371
van der Helm‐van Mil, A. H. M., Verpoort, K. N., Breedveld, F. C., Huizinga, T. W. J., Toes, R. E. M., & de Vries, R. R. P. (2006) · Arthritis & Rheumatism · doi:10.1002/art.21739 · Cited by 355
Emery, P., Deodhar, A., Rigby, W. F., Isaacs, J. D., Combe, B., Racewicz, A. J., Latinis, K., Abud-Mendoza, C., Szczepański, L. J., Roschmann, R. A., et al. (2010) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2009.119933 · Cited by 348
Self-citationEvidence for treating rheumatoid arthritis to target: results of a systematic literature search
Schoels, M., Knevel, R., Aletaha, D., Bijlsma, J. W. J., Breedveld, F. C., Boumpas, D. T., Burmester, G., Combe, B., Cutolo, M., Dougados, M., et al. (2010) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2009.123976 · Cited by 250
Self-citationKeystone, E., Emery, P., Peterfy, C. G., Tak, P. P., Cohen, S., Genovese, M. C., Dougados, M., Burmester, G. R., Greenwald, M., Kvien, T. K., et al. (2009) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2007.085787 · Cited by 227
Self-citationPatients with RA in remission on TNF blockers: when and in whom can TNF blocker therapy be stopped?
Saleem, B., Keen, H., Goeb, V., Parmar, R., Nizam, S., Hensor, E. M. A., Churchman, S. M., Quinn, M., Wakefield, R., Conaghan, P. G., et al. (2010) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2009.117341 · Cited by 206
Self-citationCTLA-4 directly inhibits osteoclast formation
Axmann, R., Herman, S., Zaiss, M., Franz, S., Polzer, K., Zwerina, J., Herrmann, M., Smolen, J., & Schett, G. (2008) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2007.080713 · Cited by 200
Alessandri, C., Bombardieri, M., Papa, N., Cinquini, M., Magrini, L., Tincani, A., & Valesini, G. (2004) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2003.014647 · Cited by 188
Harrison, B., Symmons, D. P. M., Barrett, E. M., & Silman, A. J. (1998) · PubMed · Cited by 173
Genant, H. K., Peterfy, C. G., Westhovens, R., Becker, J.-C., Aranda, R., Vratsanos, G., Teng, J., & Kremer, J. M. (2008) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2007.085084 · Cited by 158
Self-citationBuch, M. H., Boyle, D. L., Rosengren, S., Saleem, B., Reece, R. J., Rhodes, L. A., Radjenovic, A., English, A., Tang, H., Vratsanos, G., et al. (2008) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2008.091876 · Cited by 153
Self-citationUpdated consensus statement on biological agents for the treatment of rheumatic diseases, 2007
Furst, D. E., Breedveld, F. C., Kalden, J. R., Smolen, J. S., Burmester, G. R., Sieper, J., Emery, P., Keystone, E., Schiff, M., Mease, P. J., et al. (2007) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2007.081430 · Cited by 153
Self-citationThe development of the L-QoL: a quality-of-life instrument specific to systemic lupus erythematosus
Doward, L. C., McKenna, S. P., Whalley, D., Tennant, A., Griffiths, B., Emery, P., & Veale, D. J. (2008) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2007.086009 · Cited by 149
Self-citationMethods of assessing radiographic change in rheumatoid arthritis
Genant, H. K. (1983) · The American Journal of Medicine · doi:10.1016/0002-9343(83)90473-4 · Cited by 148
Self-citationMachold, K. P., Landewé, R., Smolen, J. S., Stamm, T., van der Heijde, D. M. F. M., Verpoort, K. N., Brickmann, K., Vázquez‐Mellado, J., Karateev, D. E., Breedveld, F. C., et al. (2010) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2009.122473 · Cited by 139
Self-citationChambers, C. A., Kuhns, M. S., & Allison, J. P. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.15.8603 · Cited by 129
Kekow, J., Moots, R. J., Emery, P., Durez, P., Koenig, A. S., Singh, A., Pedersen, R. D., Robertson, D., Freundlich, B., & Sato, R. (2009) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2008.102509 · Cited by 127
Self-citationJones, E., Churchman, S. M., English, A., Buch, M. H., Horner, E. A., Burgoyne, C. H., Reece, R., Kinsey, S. E., Emery, P., McGonagle, D., et al. (2009) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2008.106435 · Cited by 109
Self-citationHaugeberg, G., Conaghan, P. G., Quinn, M. A., et al. (2009) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2008.106484 · Cited by 104
Safety of biological therapies following rituximab treatment in rheumatoid arthritis patients
Genovese, M. C., Breedveld, F. C., Emery, P., Cohen, S. B., Keystone, E., Matteson, E. L., Baptiste, Y. J., Chai, A., Burke, L. S., Reiss, W. G., et al. (2009) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2008.101675 · Cited by 86
Self-citationTan, R., Gibbons, L. J., Potter, C., Hyrich, K. L., Morgan, A. W., Wilson, A. G., Isaacs, J. D., & Barton, A. C. (2010) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2009.118406 · Cited by 84
Alten, R., Zerbini, C. A. F., Jeka, S., Irazoque, F., Khatib, F., Emery, P., Bertasso, A., Rabbia, M. A., & CAULFIELD, J. P. (2009) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2008.104802 · Cited by 68
Self-citationSchoels, M., Aletaha, D., Smolen, J. S., Bijlsma, J. W. J., Burmester, G. R., Breedveld, F. C., Cutolo, M., Combe, B. G., Dougados, M., Emery, P., et al. (2009) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2009.108472 · Cited by 63
Self-citationKliwinski, C. M., Kukral, D. W., Postelnek, J., Krishnan, B. S., Killar, L. M., Lewin, A. C., Nadler, S. G., & Townsend, R. C. (2005) · Journal of Autoimmunity · doi:10.1016/j.jaut.2005.09.020 · Cited by 47
Adaptation and cross-cultural validation of the rheumatoid arthritis work instability scale (RA–WIS)
Gilworth, G., Emery, P., Gossec, L., Vlieland, T. P. M. V., Breedveld, F. C., Hueber, A. J., Schett, G. A., & Tennant, A. (2008) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2008.098921 · Cited by 47
Self-citationEyre, S., Hinks, A., Flynn, E., Martin, P., Wilson, A. G., Maxwell, J. R., Morgan, A. W., Emery, P., Steer, S. E., Hocking, L. J., et al. (2009) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2009.122887 · Cited by 47
Self-citation
Cited by
Scott, D. L., Wolfe, F., & Huizinga, T. W. (2010) · The Lancet · doi:10.1016/s0140-6736(10)60826-4 · Cited by 3,013
Smolen, J. S., Aletaha, D., Barton, A., Burmester, G. R., Emery, P., Firestein, G. S., Kavanaugh, A., McInnes, I. B., Solomon, D. H., Strand, V., et al. (2018) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2018.1 · Cited by 2,445
Self-citationTreating rheumatoid arthritis to target: recommendations of an international task force
Smolen, J. S., Aletaha, D., Bijlsma, J. W. J., Breedveld, F. C., Boumpas, D., Burmester, G., Combe, B., Cutolo, M., de Wit, M., Dougados, M., et al. (2010) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2009.123919 · Cited by 2,100
Self-citationDi Matteo, A., Bathon, J. M., & Emery, P. (2023) · The Lancet · doi:10.1016/s0140-6736(23)01525-8 · Cited by 849
Self-citationNam, J. L., Ramiro, S., Gaujoux-Viala, C., Takase, K., Leon-Garcia, M., Emery, P., Gossec, L., Landewe, R., Smolen, J. S., & Buch, M. H. (2014) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2013-204577 · Cited by 354
Self-citation
Metadata
- Authors
- Emery, P., Durez, P., Dougados, M., Legerton, C. W., Becker, J.-C., Vratsanos, G., Genant, H. K., Peterfy, C., Mitra, P., Overfield, S., Qi, K., & Westhovens, R.
- Venue
- Annals of the Rheumatic Diseases
- Publisher
- Elsevier BV
- Published
- 2010-03
- Volume
- 69
- Issue
- 3
- Pages
- 510-516
- ISSN
- 0003-4967 (ISSN-L)
- OpenAlex
- W2128713459
- Cited by
- 255
- References
- 40
- FWCI
- 18.60
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.